Eli Lilly’s diabetes, weight loss pill trial

News

28don MSN

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy ... one other weight-related health ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

8don MSN

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

Asian News International on MSN3d

Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

Some results have been hidden because they may be inaccessible to you